Immunogenicity and protection of a recombinant human adenovirus serotype 35-based malaria vaccine against Plasmodium yoelii in mice.

MLA

Ophorst, O. J. A. E., et al. “Immunogenicity and Protection of a Recombinant Human Adenovirus Serotype 35-Based Malaria Vaccine against Plasmodium Yoelii in Mice.” Infection and Immunity, vol. 74, no. 1, Jan. 2006, pp. 313–20. EBSCOhost, https://doi.org/10.1128/IAI.74.1.313-320.2006.

APA

Ophorst, O. J. A. E., Radosević, K., Havenga, M. J. E., Pau, M. G., Holterman, L., Berkhout, B., Goudsmit, J., & Tsuji, M. (2006). Immunogenicity and protection of a recombinant human adenovirus serotype 35-based malaria vaccine against Plasmodium yoelii in mice. Infection and Immunity, 74(1), 313–320. https://doi.org/10.1128/IAI.74.1.313-320.2006

Chicago

Ophorst, O J A E, K Radosević, M J E Havenga, M G Pau, L Holterman, B Berkhout, J Goudsmit, and M Tsuji. 2006. “Immunogenicity and Protection of a Recombinant Human Adenovirus Serotype 35-Based Malaria Vaccine against Plasmodium Yoelii in Mice.” Infection and Immunity 74 (1): 313–20. doi:10.1128/IAI.74.1.313-320.2006.